Acetylation of Non-histone Proteins Modulates Cellular Signalling at Multiple Levels
Overview
Cell Biology
Affiliations
This review focuses on the posttranslational acetylation of non-histone proteins, which determines vital regulatory processes. The recruitment of histone acetyltransferases and histone deacetylases to the transcriptional machinery is a key element in the dynamic regulation of genes controlling cellular proliferation and differentiation. A steadily growing number of identified acetylated non-histone proteins demonstrate that reversible lysine acetylation affects mRNA stability, and the localisation, interaction, degradation and function of proteins. Interestingly, most non-histone proteins targeted by acetylation are relevant for tumourigenesis, cancer cell proliferation and immune functions. Therefore inhibitors of histone deacetylases are considered as candidate drugs for cancer therapy. Histone deacetylase inhibitors alter histone acetylation and chromatin structure, which modulates gene expression, as well as promoting the acetylation of non-histone proteins. Here, we summarise the complex effects of dynamic alterations in the cellular acetylome on physiologically relevant pathways.
TIP60 enhances cisplatin resistance via regulating ΔNp63α acetylation in SCC.
Hira A, Zhang J, Kadakia M Cell Death Dis. 2024; 15(12):877.
PMID: 39627186 PMC: 11615348. DOI: 10.1038/s41419-024-07265-6.
Post-translational modifications in sepsis-induced organ dysfunction: mechanisms and implications.
Song L, Jiang W, Lin H, Yu J, Liu K, Zheng R Front Immunol. 2024; 15:1461051.
PMID: 39234245 PMC: 11371574. DOI: 10.3389/fimmu.2024.1461051.
Epigenetic-based differentiation therapy for Acute Myeloid Leukemia.
Jose-Eneriz E, Gimenez-Camino N, Rabal O, Garate L, Miranda E, Gomez-Echarte N Nat Commun. 2024; 15(1):5570.
PMID: 38956053 PMC: 11219871. DOI: 10.1038/s41467-024-49784-y.
Can social adversity alter the epigenome, trigger oral disease, and affect future generations?.
Khalid S, Kearney M, McReynolds D Ir J Med Sci. 2024; 193(5):2597-2606.
PMID: 38740675 PMC: 11450135. DOI: 10.1007/s11845-024-03697-3.
TransPTM: a transformer-based model for non-histone acetylation site prediction.
Meng L, Chen X, Cheng K, Chen N, Zheng Z, Wang F Brief Bioinform. 2024; 25(3).
PMID: 38725156 PMC: 11082075. DOI: 10.1093/bib/bbae219.